Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes

Archives of Internal Medicine

Volumn 159, Issue 6, 1999, Pages 601-606

  Manoukian, Mariam Avakian ^a   Foote, Julie A ^a,b   Crapo, Lawrence M ^a,b  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM; PHOSPHATE; PHOSPHORUS; POTASSIUM; POTASSIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; ELECTROLYTE DISTURBANCE; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; MALE; PERIODIC PARALYSIS; PREVALENCE; PRIORITY JOURNAL; THYROTOXICOSIS;

ADULT; FEMALE; HUMANS; HYPERKALEMIA; HYPOKALEMIA; HYPOPHOSPHATEMIA; MAGNESIUM; MALE; PARALYSES, FAMILIAL PERIODIC; PHOSPHORUS; POTASSIUM; RETROSPECTIVE STUDIES; THYROTOXICOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033594221     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.6.601     Document Type: Article

References (48)

1. Okinaka S, Shizume K, Lino S, et al. The association of periodic paralysis and hyperthyroidism in Japan. J Clin Endocrinol Metab. 1957;17:1454-1459.
2. Shizume K, Shishiba Y, Kuma K, et al. Comparison of the incidence of association of periodic paralysis and hyperthyroidism in Japan in 1957 and 1991. Endocrinol Jpn. 1992;39:315-318.
3. McFadzean AJS, Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. BMJ. 1967;1:451-455.
4. Ko GTC, Chow CC, Yeung VTF, et al. Thyrotoxic periodic paralysis in a Chinese population. QJM. 1996;89:463-468.
5. Conway MJ, Seibel JA, Eaton RP. Thyrotoxicosis and periodic paralysis: improvement with beta blockade. Ann Intern Med. 1974;81:332-336.
6. Yeo PPB, O'Neill WC. Thyrotoxicosis and periodic paralysis. Med Grand Rounds. 1984;3:10-25.
7. Ferreiro JE, Arguelles DJ, Rams H. Thyrotoxic periodic paralysis. Am J Med. 1986; 80:146-150.
8. Tinker TD, Vannata JB. Thyrotoxic hypokalemic periodic paralysis: report of four cases and review of the literature. J Okla State Med Assoc. 1987;80:11-15, 76-83.
9. Saeian K. Heckerling PS. Thyrotoxic periodic paralysis in a Hispanic man. Arch Intern Med. 1988;148:708.
10. Bergeron L, Sternbach GL. Thyrotoxic periodic paralysis. Ann Emerg Med. 1988; 17:843-845.
11. Kelley DE, Gharib H, Kennedy FP, Duda RJ, McManis PG. Thyrotoxic periodic paralysis: report of 10 cases and review of electromyographic findings. Arch Intern Med. 1989;149:2597-2600.
12. Ober KP. Thyrotoxic periodic paralysis in the United States: report of 7 cases, a review of the literature. Medicine. 1992;71:109-120.
13. Dunlap HF, Kepler EJ. A syndrome resembling familial periodic paralysis occurring in the course of exophthalmic goiter. Endocrinology. 1931;15:541-546.
14. Lawrence GD, Chwa E, Balagtas R. Case report, thyrotoxic periodic paralysis. Md Med J. 1990;39:583-587.
15. Capobianco D. Hyperthyroidism and periodic paralysis. J Fla Med Assoc. 1990; 77:884-888.
16. Woolery WA, Gharib H. Thyrotoxic hypokalemic periodic paralysis in a white man. South Med J. 1991;84:1399-1401.
17. Kilpatrick RE, Seiler-Smith S, Levine SN. Thyrotoxic hypokalemic periodic paralysis: report of four cases in black American males. Thyroid. 1994;4:441-445.
18. Yeo PPB, Chan SH, Lui KF, Wee GB, Lim P, Cheah IS. HLA and thyrotoxic periodic paralysis. BMJ. 1978;2:930.
19. Araya P, Silva C, Piraino P, Wegman ME. HLA antigens typification in two Hispanic patients with thyrotoxic periodic paralysis. Muscle Nerve. 1996;19:677-678.
20. Talbott JH. Periodic paralysis. Medicine. 1941;20:85-142.
21. Feely J. Potassium shift in thyrotoxic periodic paralysis. Postgrad Med J. 1981; 57:238-239.
22. Darrow M, Brammer WK, Rowley A. Thyrotoxic periodic paralysis: two case studies. Arch Phys Med Rehabil. 1995;76:685-687.
23. Shayne P, Hart A. Thyrotoxic periodic paralysis terminated with intravenous propranolol. Ann Emerg Med. 1994;24:736-740.
24. Nora NA, Berns AS. Hypokalemic, hypophosphatemic thyrotoxic periodic paralysis. Am J Kidney Dis. 1989;13:247-249.
25. Fisher J. Thyrotoxic periodic paralysis with ventricular fibrillation. Arch Intern Med. 1982;142:1362-1364.
26. Guthrie G, Curtis J, Beilman K. Hypophosphatemia in thyrotoxic periodic paralysis. Arch Intern Med. 1978;138:1284-1285.
27. Norris KC, Levine B, Ganesan K. Case report: thyrotoxic periodic paralysis associated with hypokalemia and hypophosphatemia. Am J Kidney Dis. 1996;28: 272-273.
28. Knochel JP. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med. 1977;137:203-214.
29. Singhal PC, Kumar A, Desroches L, Gibbons N, Mallana J. Prevalence and predictors of rhabdomyolysis in patients with hypophosphatemia. Am J Med. 1992; 92:458-460.
30. Singhal PC, Venkatesan J, Gibbons N, Gibbons J. Prevalence and predictors of rhabdomyolysis in patients with hypokalemia. N Engl J Med. 1990;323: 1488.
31. Ryzen E, Servis KL, Rude RK. Effect of intravenous epinephrine on serum magnesium and free intracellular red blood cell magnesium concentrations measured by nuclear magnetic resonance. J Am Coll Nutr. 1990;9:114-119.
32. Schimke RN. Hyperthyroidism: the clinical spectrum. Postgrad Med. 1992;91: 229-236.
33. Ee B, Cheah JS. Electrocardiographs changes in thyrotoxic periodic paralysis. J Electrocardiol. 1979;12:263-279.
34. Davidson ET, Davidson MJ. Triiodothyronine (T3) toxicosis with hypokalemic periodic paralysis and ventricular tachycardia. J Electrocardiol. 1995;28: 161-164.
35. Miller C. Potassium selectivity in proteins: oxygen cage or Pi in the face? Science. 1993;261:1692-1693.
36. Ackerman MJ, Clapham DE. Ion channels: basic science and clinical disease. N Engl J Med. 1997;336:1575-1586.
37. Lin MH, Akera T. Increased Na, K-ATPase concentrations in various tissues of rats caused by thyroid hormone treatment. J Biol Chem. 1978;253:723-726.
38. Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ. 1991; 303:1096-1099.
39. Lee KO, Taylor EA, Oh VM, Cheah JS, Aw SE. Hyperinsulinaemia in thyrotoxic hypokalaemic periodic paralysis. Lancet. 1991;337:1063-1064.
40. Shishiba Y, Shimizu T, Saito T, Shizume K. Elevated immunoreactive insulin concentration during spontaneous attacks in thyrotoxic periodic paralysis. Metabolism. 1972;21:285-290.
41. Minaker KL, Maneilly GS, Flier JS, Rowe JW. Insulin-mediated hypokalemia and paralysis in familial hypokalemic periodic paralysis. Am J Med. 1988;84:1001-1006.
42. Clausen T, Kohn PG. The effect of insulin on the transport of sodium and potassium in rat soleus muscle. J Physiol. 1977;265:19-42.
43. Satoyoshi E, Suzuki Y, Abe T. Periodic paralysis: a study of carbohydrate and thiamine metabolism. Neurology. 1963;13:24-33.
44. Bilezikian JP, Loeb JN. The influence of hyperthyroidism and hypothyroidism on adrenergic receptor systems and adrenergic responsiveness. Endocr Rev. 1983; 4:378-387.
45. Body JJ, Cryer PE, Offord KP, Heath H. Epinephrine is a hypophosphatemic hormone in man. J Clin Invest. 1983;71:572-578.
46. Chronos N, Mendel P, Ozin RL. Thyrotoxicosis presenting as a life threatening hypokalaemic paralysis: investigation of the Na/K pump in isolated leucocytes. Br J Clin Pract. 1993;47:106-108.
47. Yeung RTT, Tse TF. Thyrotoxic periodic paralysis: effect of propranolol. Am J Med. 1974;57:584-590.
48. Van Cauter E, Shapiro ET, Tillil H, Polonsky H. Circadian modulation of glucose and insulin responses to meals: relationship to cortisol rhythm. Am J Physiol. 1992;262:E467-E475.